Skip to main content

Llewelyn Linda's Form 4 filing

Health Catalyst, Inc. (HCAT) · filed Jan 6, 2022

Accession no.
0001562180-22-000329
Filed
Jan 6, 2022
Trade date
Jan 4, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $130.1K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Llewelyn LindaCIK 0001780878Officer (Chief People Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 4, 2022Common StockMOption exerciseAcquired+2,050$10.80+$22,14033,016Direct
Jan 4, 2022Common StockMOption exerciseAcquired+1,100$11.78+$12,95834,116Direct
Jan 4, 2022Common StockSSaleDisposed−3,234$40.23−$130,103.8230,882Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 4, 2022Common StockMOption exerciseDisposed−1,100$0.00$04,754Direct
Jan 4, 2022Common StockMOption exerciseDisposed−950$0.00$06,920Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)